Drug intelligence / Profile preview

umbilical cord serum eye drops (Chonnam National University Hospital, f5b5d7)

Development stage
Unknown
Lead developer
Chonnam National University Hospital
Administration
Ophthalmic
01

Overview

Umbilical cord serum eye drops is a biologic therapy developed by researchers at Chonnam National University Hospital for the treatment of severe dry eye syndrome. The formulation typically consists of 20% umbilical cord serum derived from umbilical cord blood collected during delivery. This serum contains high concentrations of essential tear components and bioactive factors, including epidermal growth factor (EGF), transforming growth factor-beta (TGF-beta), insulin-like growth factor-1 (IGF-1), nerve growth factor (NGF), vitamin A, and fibronectin. The therapy works by providing a nutrient-rich environment that promotes the proliferation, migration, and differentiation of the ocular surface epithelium, facilitating the repair of keratoepitheliopathy. Clinical research has demonstrated its efficacy in treating severe dry eye associated with Sjögren's syndrome and graft-versus-host disease, often showing superior results compared to autologous serum eye drops.

Other names
20% umbilical cord serum eye dropsUCS eye dropsumbilical cord serumumbilical cord serum-Chonnam National University Hospital
02

Targets

EGFR (Epidermal growth factor receptor)IGF-1R (Insulin-like growth factor 1 receptor)NTRK1 (Tropomyosin-related receptor kinase A)TGFBR (TGF-beta receptor)NGFR (p75NTR)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on umbilical cord serum eye drops (Chonnam National University Hospital, f5b5d7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on umbilical cord serum eye drops (Chonnam National University Hospital, f5b5d7).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call